Capricor Therapeutics, Inc. (CAPR) vs ProKidney Corp. (PROK)
Capricor Therapeutics, Inc. and ProKidney Corp. are both Biotechnology companies. Capricor Therapeutics, Inc. and ProKidney Corp. are of similar size ($514.0M and $508.7M). Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −10,288.4%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 13 metrics below, Capricor Therapeutics, Inc. leads on 7 and ProKidney Corp. on 6.
Valuation
Profitability
| Metric | CAPR | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (21,664.55%) | 0.00% |
| Net margin | 0.00% | (10,288.39%) | 0.00% |
| Free cash flow margin | 0.00% | (17,300.61%) | 0.00% |
| Return on equity | (73.70%) | 8.92% | (57.72%) |
| Return on assets | (51.53%) | (27.10%) | (49.22%) |
| Return on invested capital | (1,019.73%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack